Baidu Health has entered into a strategic partnership with HOB Biotech Group, a leading in vitro diagnostic (IVD) specialist in China, to develop a new model that combines allergy detection, desensitization treatment, and Internet+ technologies. The collaboration aims to create a comprehensive approach to allergy management without disclosing financial details.<\/p>\n\n\n\n
HOB Biotech’s Expertise and the Partnership’s Focus<\/strong>
As China’s first and only listed company specializing in allergy detection, HOB Biotech Group is dedicated to the research, development, and manufacturing of IVD reagents for allergy and autoimmune disease diagnostics. The partnership will leverage the combined strengths of both companies, working with a team of authoritative medical experts to promote a “four in one” scientific model based on allergen testing. This model will be disseminated through various popular science education methods, including live streaming, video, image, text, and academic literature interpretation, to enhance public awareness of allergic diseases.<\/p>\n\n\n\n